ADC Therapeutics Income Statement (2019-2023) | ADCT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023
Revenue & cost
Revenue	0.00B	0.00B	222.00	0.00B		145.00		0.00B	13.15		0.05B	0.02B	0.08B	69.80B	0.02B	0.02B	0.01B
Cost of Revenue				0.00B			0.01B	0.00B	0.00B	770.00	0.00B	0.00B	0.00B	0.49B	0.00B	0.01B	0.01B
Gross Profit							-0.01B	0.00B	-0.00B	17.01B	0.05B	0.02B	0.08B	69.31B	0.02B	0.00B	0.00B
Operating items
Amortization - Intangibles		-2.00	19.00	0.00B			25.00	38.00	33.00	33.00	26.00	31.00	31.00	30.00	52.00	51.00	52.00
Research & Development	-0.00B	-0.00B	-0.00B	0.04B	-0.03B	-0.03B	-0.04B	-0.04B	-0.04B	-0.00B	-0.05B	-0.05B	-0.04B	-0.00B	-0.04B	0.03B	0.03B
Selling, General & Administrative	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.00B	-0.02B	-0.02B	-0.02B	-0.00B	-0.02B	0.01B	0.01B
Other Operating Expenses				-0.07B	-0.00B	-0.01B	-0.01B	-0.02B	0.05B		4.86B	4.64B	-0.02B	-0.00B	3.71B	0.02B	0.01B
Operating Expenses	-0.00B	-0.00B	-0.00B	-0.04B	-0.04B	-0.05B	-0.07B	-0.07B	0.00B	-0.00B	4.79B	4.58B	-0.08B	-0.00B	3.65B	0.06B	0.05B
Operating Income	-0.00B	-0.00B	-0.00B	-43.89	-44.95	-52.43	-0.07B	-0.07B	-0.06B	-62.78B	-0.04B	-0.07B	-0.00B	-10.74B	-0.05B	3.02B	-0.04B
EBIT	-0.00B	-0.00B	-0.00B	-43.89	-44.95	-52.43	-0.07B	-0.07B	-0.06B	-62.78B	-0.04B	-0.07B	-0.00B	-10.74B	-0.05B	3.02B	-0.04B
Non-operating items
Interest & Investment Income																0.00B	0.00B
Other Non Operating Income	10.00	-360.00	222.00	-0.00B	-100.00	0.00B	-366.00		-0.01B	0.00B	0.01B	0.01B	-0.04B	-0.00B	-0.00B	-0.01B	0.00B
Non Operating Income	633.00	0.00B	562.00	0.00B	-0.08B	0.03B	0.02B	-0.00B	-0.01B	0.00B	0.02B	0.00B	-0.05B	-0.00B	-0.01B	-0.01B	-0.01B
Net income details
EBT	-0.00B	-0.00B	-0.00B	-0.04B	-0.13B	-0.02B	-0.05B	-0.07B	-0.07B	-0.00B	-0.02B	-0.07B	-0.05B	-0.00B	-0.06B	-0.05B	-0.05B
Tax Provisions	-94.00	-268.00	-115.00	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	-0.00B	-0.00B
Profit After Tax	-0.00B	-0.00B	-0.00B	0.04B	-0.13B	-0.02B	-0.00B	0.00B	0.00B	-0.00B	-0.02B	-0.06B	-0.05B	-0.00B	-0.00B	-0.05B	-0.05B
Equity Income																-0.00B	-0.00B
Income from Continuing Operations	-0.00B	-0.00B	-0.00B	-0.04B	-0.13B	-0.02B	-0.05B	-0.07B	-0.07B	-0.00B	-0.02B	-0.07B	-0.05B	-0.00B	-0.06B	-0.05B	-0.05B
Consolidated Net Income	-0.00B	-0.00B	-0.00B	-0.04B	-0.13B	-0.02B	-0.05B	-0.07B	-0.07B		-0.02B	-0.07B	-0.05B	-0.00B	-0.06B	-0.05B	-0.05B
Income towards Parent Company	-0.00B	-0.00B	-0.00B	0.04B	0.13B	0.02B	0.05B	0.07B	0.07B	-0.00B	0.02B	0.06B	0.05B	-0.00B	-0.00B	-0.00B	-0.00B
Net Income towards Common Stockholders	-0.00B	-0.00B	-0.00B	0.04B	0.13B	0.02B	0.05B	0.07B	0.07B		0.02B	0.06B	0.05B	-0.00B	-0.00B	-0.00B	-0.00B
Additional items
EPS (Basic)				0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00	0.00B	0.00B	0.00B	0.00	-80.31	-0.60	-0.57
EPS (Weighted Average and Diluted)						0.00B	0.00B	0.00B	0.00B		0.00B	0.00B	0.00B		-80.31	-0.60	-0.57
Shares Outstanding (Weighted Average)				850.00	0.00B	0.00B	670.00	0.00B	0.00B	0.08B	220.00	0.00B	0.00B	0.08B	740.00	0.00B	0.08B
Shares Outstanding (Diluted Average)						0.00B	670.00	0.00B	0.00B		220.00	0.00B	0.00B		740.00	0.08B	0.08B
EBITDA	-0.00B	-0.00B	-0.00B	-43.89	-44.95	-52.43	-0.07B	-0.07B	-0.06B	-62.78B	-0.04B	-0.07B	-0.00B	4.35B	-0.05B	2.47B	2.72B
Interest Expenses																0.01B	0.01B
Tax Rate	0.40%	0.86%	0.33%	0.23%	0.08%	-0.01%	0.21%	0.33%	0.20%	-911.20%	-6.56%	-1.45%	-1.39%	19.65%	-0.44%	8.54%	0.22%

Research Tools

ADC Therapeutics Income Statement (2019-2023) | ADCT

Create an account

Sign In

Reset Password